[1]
Rahman, M.A., Ahmed, M.A., Akter, S., Nasrin, P., Islam, I.A., Akhter, N., R. Kabir, M.M., Poddar, S.C., H. Masud, M.A. and Shah, M.S. 2024. Assessment of measurable residual disease after induction chemotherapy in acute lymphoblastic leukemia patients in a tertiary care hospital. International Journal of Advances in Medicine. 11, 5 (Aug. 2024), 428–433. DOI:https://doi.org/10.18203/2349-3933.ijam20242303.